Showing 831-840 of 1205 results for "".
- Thermi Debuts Arvati Platformhttps://modernaesthetics.com/news/themi-debuts-arvati-platform/2472041/Thermi, an Almirall company, is launching Arvati, a next-generation 510K US Food and Drug Administration-cleared, true temperature-controlled radiofrequen
- Thermi Receives Health Canada Clearance to Market Thermi RF for Dermal Laxityhttps://modernaesthetics.com/news/there-receives-health-canada-clearance-to-market-thermi-rf-for-dermal-laxity/2472079/Therm
- Back by Popular Demand: Sciton's Bright Lights Big City BBL Tourhttps://modernaesthetics.com/news/back-by-popular-demand/2472107/Sciton. Inc.’s
- Revance, Mylan Partner to Develop Botox Biosimilarhttps://modernaesthetics.com/news/revance-mylan-partner-to-develop-botox-biosimilar/2472123/Mylan N.V. and
- Milestone Scientific Gears Up To Launch New Botox Delivery Instrumenthttps://modernaesthetics.com/news/milestone-scientific-gears-up-to-launch-new-botox-delivery-instrument/2472162/Botulinum toxin injections may be about to get smarter and more comfortable as Milestone Scientific Inc. readies to launch its novel and proprietary cosmetic injection instrument. The new cosmetic injection instrument
- Galderma Rolls Out Restylane Refyne, Defynehttps://modernaesthetics.com/news/galderma-rolls-out-restylane-refyne-defyne/2472262/With a growing number of hyaluronic acid (HA) fillers available and even more in the pike, Galderma is highlighting how their two newest fillers --
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Study Finds High-Intensity, Parallel Beam Ultrasound-Based Skin Tightening Effective For Improving Upper Arm Skin Laxity, Crepinesshttps://modernaesthetics.com/news/study-finds-high-intensity-parallel-beam-ultrasound-based-skin-tightening-effective-for-improving-upper-arm-skin-laxity-crepiness/2483859/A study published in Dermatologic Surgery evaluated and compared the efficacy of high-intensity, parallel beam ultrasound-based skin tightening (HIUS) device with microfocused ultrasound with visualization (MFU-V) for the improvement of upper arm skin laxity and crepiness. The pr
- CollPlant Advances Light-Activated Regenerative Filler Toward Clinical Trialshttps://modernaesthetics.com/news/collplant-advances-light-activated-regenerative-filler-toward-clinical-trials/2483589/CollPlant Biotechnologies has announced the completion of a nonclinical program supporting the development of its photocurable dermal filler, which combines hyaluronic acid with a modified form of recombinant human collagen (rhCollagen). The company plans to advanc
- Study Evaluates Ready-To-Use Botox for Lateral Canthal, Glabellar Lines Treatmenthttps://modernaesthetics.com/news/study-evaluates-ready-to-use-botox-for-lateral-canthal-glabellar-lines-treatment/2483549/Newly published research in Dermatologic Surgery found liquid nivobotulinumtoxinA was effective and well-tolerated in treating moderate-to-severe lateral canthal lines (LCLs) and glabellar lines (GLs). Jean Carruthers, MD, FRCSC, FRC, co-authored the study, titled “NivobotulinumtoxinA in